Clinical Trial

Recto-intercostal Block for Coronary Artery Bypass Grafting

Active, Not Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated March 19, 2025 (before its estimated May 1, 2025 completion). Its status may not reflect the trial's current state.
Summary
This interventional study aims to learn about the postoperative analgesic efficacy of a new fascial plane block, recto-intercostal fascial plane block, at coronary artery bypass grafting with sternotomy. There will be two groups, one of which will be the control group, and the other will be the study group randomly receiving postoperative recto-intercostal fascial plane block. The main questions it aims to answer are the effect of this new block on postoperative opioid consumption and pain scores. Also, postoperative outcomes related to respiratory ( postoperative oxygenation and atelectasis score), hemodynamic functions ( newly developed arrhythmias), total postanesthesia care unit stay, and hospital stay will be questioned.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-05-13.
Status change: Recruiting → Active, Not Recruiting 2025-03-17
Trial Details
NCT Number NCT06418100
Lead Sponsor Haseki Training and Research Hospital
Conditions Coronary Artery Disease, Peripheral Nerve Blocks, Sternotomy
Enrollment 60 participants
Start Date 2024-03-01
Primary Completion 2025-05-01 (estimated)
Study Completion 2025-06-01 (estimated)
Updated on ClinicalTrials.gov 2025-03-19